These results may be explained on the basis that the high serum IL-10 levels in patients with HCC result from the secretion of IL-10 by tumor cells, in addition to the production at the site of inflammatory changes with activated infiltrating mononuclear cells in the liver [22]. The gene discussed is IL10; the disease is hepatocellular carcinoma.